Učitavanje...

A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

OBJECTIVES: Combinations of gemcitabine, 5-fluorouracil (5-FU), and platinum have demonstrated improved outcomes compared with singlet chemotherapy in pancreatic and biliary cancers. This phase II study examined efficacy and safety of a novel schedule of cisplatin, fixed-dose-rate (FDR) gemcitabine...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Clin Oncol
Glavni autori: Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854803/
https://ncbi.nlm.nih.gov/pubmed/26535993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000240
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!